COVID-19 Lockdown Study Reveals Critical Insights for Type 1 Diabetes Management in Young Adults — Implications for Clinical Practice

References

1. 1.Centre Hospitalier Sud Francilien. (2020). Observational Study of Glycemic Control and Self-management of Young People (Aged 13 to 25 Years) With Type 1 Diabetes During COVID-19 Lockdown. ClinicalTrials.gov. NCT04669912. https://clinicaltrials.gov/study/NCT04669912
2. 2.Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., ... & T1D Exchange Clinic Network. (2019). State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018. Diabetes Technology & Therapeutics, 21(2), 66-72. https://doi.org/10.1089/dia.2018.0384
3. 3.Hilliard, M. E., Wu, Y. P., Rausch, J., Dolan, L. M., & Hood, K. K. (2013). Predictors of deteriorations in diabetes management and control in adolescents with type 1 diabetes. Journal of Adolescent Health, 52(1), 28-34. https://doi.org/10.1016/j.jadohealth.2012.11.009
4. 4.Ruiz de Adana, M. S., Colomo, N., Maldonado-Araque, C., Fontalba, M. I., Linares, F., García-Torres, F., ... & Valdés, S. (2021). Randomized clinical trial of the efficacy and safety of insulin glargine vs NPH insulin in the treatment of gestational diabetes mellitus. American Journal of Obstetrics and Gynecology, 224(2), 196.e1-196.e9. https://doi.org/10.1016/j.ajog.2020.09.006
5. 5.Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329(14), 977-986. https://doi.org/10.1056/NEJM199309303291401